logo
[breadcrumb_custom]

Tag: TGTX Shares

Stock

TGTX: Riding the Market Waves of Growth and Decline in 2023

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -19.09%.However, over the last six months, we can see a weaker performance of 103.24%. Over the last 30 days, the price of TGTX has leaped by -8.17%. And in the last five days, it has fallen by -6.05%. TG Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $35.67 on 05/04/23 and the lowest value

Stock

TGTX: Riding the Market Waves of Growth and Decline in 2023

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded a decrease of -15.46%. However, over the last six months, the performance has been weaker by 86.32%. The price of TGTX decreased -20.79% over the last 30 days. And in the last five days, it has fallen by -5.06%. The market performance of TG Therapeutics Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $35.67 on 05/04/23, with

ALXO Stock
Industry

TG Therapeutics Inc (TGTX) Stock: A Year of Stock Market Dynamics

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. TG Therapeutics Inc’s current trading price is -57.25% away from its 52-week high, while its distance from the 52-week low is 136.07%. The stock’s price range for this time frame has been between $6.46 and $35.67. The trading volume of the company’s shares in the Healthcare reached around 2.15 million for the day, which was evidently lower than the average daily volume of 4.89 million over the last three months. The stock market performance of TG Therapeutics Inc has

PNC Stock
News

TG Therapeutics Inc (TGTX) Stock: A 52-Week Tale of Drops and Gains

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. TG Therapeutics Inc’s current trading price is -55.90% away from its 52-week high, while its distance from the 52-week low is 143.50%. The stock’s price range during this period has varied between $6.46 and $35.67. The company, active in the Healthcare sector, saw a trading volume of around 2.68 million for the day, considerably lower average daily volume of 5.18 million observed over the last three months. TG Therapeutics Inc’s stock market performance has been

VIPS stock
Industry

TGTX’s 52-Week Rollercoaster: From $6.46 to $35.67 – What’s Next for Investors?

TG Therapeutics Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $35.67 on 05/04/23, while the lowest price during the same period was $6.46 on 10/16/23. 52-week price history of TGTX Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. TG Therapeutics Inc’s current trading price is -48.61% away from its 52-week high, while its distance from the 52-week low is 183.75%. The stock’s price range during this period has fluctuated between $6.46

Finance

TGTX Stock: Exploring TG Therapeutics Inc’s Growth

TG Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $35.67 on 05/04/23, while the lowest price for the same period was registered at $6.46 on 10/16/23. 52-week price history of TGTX Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. TG Therapeutics Inc’s current trading price is -60.61% away from its 52-week high, while its distance from the 52-week low is 117.49%. The stock’s price range during this period has spanned from $6.46 to $35.67. In the Healthcare sector, the